Teplice Hospital
- Address
- Duchcovská 962/53, 415 29 Teplice, Czechia
Teplice Hospital - Respiratory Infection Research
Teplice Hospital is actively engaged in critical care and infectious disease research, with a particular focus on severe respiratory tract infections requiring hospitalization. The center participates in large-scale international collaborative studies examining novel therapeutic approaches and treatment strategies for patients with acute respiratory conditions.
- Community-acquired pneumonia treatment optimization
- Acute respiratory tract infection management
- Critical care outcomes research
The hospital's research program emphasizes adaptive platform trial methodology, enabling the simultaneous evaluation of multiple interventions in hospitalized patients. This innovative approach allows for comprehensive assessment of treatment effects on 90-day mortality and recovery trajectories, contributing valuable evidence to improve outcomes for patients with severe respiratory infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Teplice Hospital
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Oseltamivir and Drug Combinations in Hospitalized Patients with Acute Respiratory Tract Infection: A Randomized Adaptive Platform Trial | Universitair Medisch Centrum Utrecht | Phase III | Recruiting | Feb 2016 | — |
IMP list
lock Showing 1 of 19 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin Sodium | 1 | Unknown | 2016-02-19 | 2016-02-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.